Related Experiment Video
Updated: Apr 14, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Unmet Needs in Eosinophilic Esophagitis: Do We Still Have Some?
Amiko M Uchida1, Kathryn Peterson1
1Division of Gastroenterology, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
Eosinophilic esophagitis (EoE) care faces challenges in diagnosis, predicting treatment response, and long-term management. Ongoing research aims to address these knowledge gaps for improved patient outcomes.
Area of Science:
- Gastroenterology
- Immunology
- Allergy
Background:
- Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus.
- Characterized by eosinophilic infiltration and esophageal symptoms, EoE has seen increased understanding of its epidemiology and pathogenesis.
- Despite advances, significant knowledge gaps persist in clinical care.
Purpose of the Study:
- To review current limitations in the clinical care of EoE.
- To highlight unmet needs in diagnosis, treatment prediction, and long-term management.
- To discuss areas requiring further investigation for improved patient outcomes.
Main Methods:
- Literature review focusing on current EoE management challenges.
- Analysis of existing data on diagnostic methods, therapeutic strategies, and monitoring.
- Identification of key areas for future research and clinical application.
Main Results:
- Current EoE care struggles with uncertainties in predicting complications and therapy response.
- Limited data exists for long-term inflammation control and clinically applicable biomarkers for phenotype prediction.
- Key limitations include diagnosis, food antigen testing, phenotype prediction, maintenance strategies, disease endpoints, and monitoring.
Conclusions:
- Despite advances in understanding EoE, patients face unmet needs.
- Ongoing research is actively addressing current deficiencies in EoE care.
- Future investigations are expected to resolve many of the current limitations, improving clinical management.
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

